Jarden Corporation

Shareholder Corporation Litigation

Rigrodsky & Long, P.A. Announces Investigation Of Jarden Corporation (NYSE: JAH) Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Jarden Corporation (“Jarden” or the “Company”) (NYSE: JAH) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Newell Rubbermaid Inc. (“Newell Rubbermaid”) (NYSE: NWL).

Under the terms of the agreement, shareholders of Jarden will receive $21.00 in cash and 0.862 shares of Newell Rubbermaid for each share of Jarden.  Based on Newell Rubbermaid’s closing stock price on December 11, 2015, Jarden shareholders would have received compensation valued at approximately $60.03 per share.

The investigation concerns whether Jarden’s board of directors failed to adequately shop the Company and obtain the best possible value for Jarden’s shareholders before entering into an agreement with Newell Rubbermaid.  According to Yahoo! Finance, at least one analyst has issued a price target for Jarden stock at $65.00 per share.

If you own the common stock of Jarden and purchased your shares before December 14, 2015, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.